Skip to content
healthcare.dev

TOFACITINIB

NDC 76282-816, TOFACITINIB, tablet, film coated, extended release, from Exelan pharmaceuticals,Inc.

Product NDC
76282-816
Status
Listed
Labeler
Exelan pharmaceuticals,Inc
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219830
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76282-816 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE11 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
76282-816-307628208163030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (76282-816-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e68680e5-0328-4e66-b8bb-4af126221ec7
  • NADAC price for package 76282081630

    GET /v1/drugs/nadac/76282081630

Use it

Look up 76282-816 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76282-816 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76282-816. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.